Open AccessSecukinumab: The Anti-IL-17A Biologic for the Treatment of Psoriasis
Author(s) -
Maria Concetta Fargnoli
Publication year - 2019
Publication title -
case reports in dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.338
H-Index - 18
ISSN - 1662-6567
DOI - 10.1159/000501991
Subject(s) - secukinumab , medicine , psoriasis , interleukin 23 , interleukin 17 , plaque psoriasis , dermatology , ustekinumab , immunology , cytokine , tumor necrosis factor alpha , psoriatic arthritis , infliximab